Literature DB >> 23197222

Risk factors for hidradenitis suppurativa: a pilot study.

Juliano Vilaverde Schmitt1, Giovana Bombonatto, Manoela Martin, Hélio Amante Miot.   

Abstract

The hidradenitis suppurativa is a chronic debilitating inflammatory disease whose etiology is not fully understood. We conducted a pilot case-control study matched by sex and age with other dermatological patients to analyze possible risk factors associated with this disease. We included 15 cases and 45 controls, 67% were women. Bivariate and multivariate logistic regression analysis identified significant association with smoking, higher body mass index and family history. The use of hormonal contraceptives was less frequent in women with hidradenitis.

Entities:  

Mesh:

Year:  2012        PMID: 23197222      PMCID: PMC3699910          DOI: 10.1590/s0365-05962012000600024

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  10 in total

1.  Hidradenitis suppurativa.

Authors:  B C Gee; R P Dawber
Journal:  J R Soc Med       Date:  2000-12       Impact factor: 5.344

Review 2.  Hidradenitis suppurativa.

Authors:  P S Mortimer; P J Lunniss
Journal:  J R Soc Med       Date:  2000-08       Impact factor: 5.344

3.  Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3.

Authors:  Min Gao; Pei-Guang Wang; Yong Cui; Sen Yang; Yu-Hui Zhang; Da Lin; Kai-Yue Zhang; Yan-Hua Liang; Liang-Dan Sun; Kai-Lin Yan; Feng-Li Xiao; Wei Huang; Xue-Jun Zhang
Journal:  J Invest Dermatol       Date:  2006-06       Impact factor: 8.551

4.  Hidradenitis suppurativa and smoking.

Authors:  Thierry Simonart
Journal:  J Am Acad Dermatol       Date:  2010-01       Impact factor: 11.527

5.  Familial acne inversa with acne conglobata in three generations.

Authors:  P V S Prasad; P K Kaviarasan; Joe Mathew Joseph; S Madhuri; P Viswanathan
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 May-Jun       Impact factor: 2.545

6.  Hidradenitis suppurativa and associated factors: still unsolved problems.

Authors:  Lukasz Matusiak; Andrzej Bieniek; Jacek Cezary Szepietowski
Journal:  J Am Acad Dermatol       Date:  2009-08       Impact factor: 11.527

7.  Pathogenesis, clinical features and management of hidradenitis suppurativa.

Authors:  P Rorison; M Ghosh
Journal:  Ann R Coll Surg Engl       Date:  1997-09       Impact factor: 1.891

8.  Pathogenesis, clinical features and management of hidradenitis suppurativa.

Authors:  L E Hughes
Journal:  Ann R Coll Surg Engl       Date:  1997-07       Impact factor: 1.891

9.  [Hidradenitis suppurativa treated with infliximab].

Authors:  Daniel Lago Obadia; Egon Luiz Rodrigues Daxbacher; Thiago Jeunon; Alexandre Carlos Gripp
Journal:  An Bras Dermatol       Date:  2009 Nov-Dec       Impact factor: 1.896

10.  Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy.

Authors:  John N Kraft; Gordon E Searles
Journal:  J Cutan Med Surg       Date:  2007 Jul-Aug       Impact factor: 2.092

  10 in total
  7 in total

1.  Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group.

Authors:  Isabel Greco Tavora; Gabriela Cabral Bissoli; Hélio Amante Miot; Juliano Vilaverde Schmitt
Journal:  An Bras Dermatol       Date:  2019-07-29       Impact factor: 1.896

Review 2.  Hormonal Contraceptives and Dermatology.

Authors:  Natalie M Williams; Michael Randolph; Ali Rajabi-Estarabadi; Jonette Keri; Antonella Tosti
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

Review 3.  Hidradenitis suppurativa in children and adolescents: a review of treatment options.

Authors:  Peter Riis Mikkelsen; Gregor B E Jemec
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

4.  Incidence of skin diseases diagnosed in a public institution: comparison between 2003 and 2014.

Authors:  Livia Maria Zanardi Miguel; Marilia Formentini Scotton Jorge; Bruna Rocha; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

5.  Hidradenitis suppurativa: epidemiological study of cases diagnosed at a dermatological reference center in the city of Bauru, in the Brazilian southeast State of São Paulo, between 2005 and 2015.

Authors:  Tatiana Cristina Pedro Cordeiro de Andrade; Bruna Cortinóvis Vieira; Agnes Mayumi Nakano Oliveira; Tábata Yamasaki Martins; Tatiane Meira Santiago; Antônio Carlos Ceribelli Martelli
Journal:  An Bras Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.896

Review 6.  Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.

Authors:  Amit Garg; Neeta Malviya; Andrew Strunk; Shari Wright; Afsaneh Alavi; Raed Alhusayen; Ali Alikhan; Steven D Daveluy; Isabelle Delorme; Noah Goldfarb; Wayne Gulliver; Iltefat Hamzavi; Tarannum Jaleel; Alexa B Kimball; Joslyn S Kirby; Mark G Kirchhof; Janice Lester; Hadar Lev-Tov; Michelle A Lowes; Robert Micheletti; Lauren A Orenstein; Vincent Piguet; Christopher Sayed; Jerry Tan; Haley B Naik
Journal:  J Am Acad Dermatol       Date:  2021-01-23       Impact factor: 15.487

7.  Confluent and reticulate papillomatosis of Gougerot-Carteaud and obesity: dermoscopic findings.

Authors:  Fred Bernardes Filho; Maria Victória Quaresma; Fernanda Coelho Rezende; Bernard Kawa Kac; José Augusto da Costa Nery; Luna Azulay-Abulafia
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.